The reserved portion of qualified institutional buyers oversubscribed 144.62 times while the portion set aside for non-institutional investors subscribed 277.74 times and that of retail investors 7.51 times, according to CNBC-TV18.
SP Tulsian, sptulsian.com, shares his views on the newly listed Advanced Enzymes and explains why he is bullish on the stock. He also talks about Crompton Consumer's numbers in the first quarter earnings. He also discusses Tata Steel and the UK limbo.
The initial public offerings of drug maker Alkem Laboratories and diagnostic chain Dr Lal PathLabs attracted strong investor demand till late afternoon on the last day of bidding today.
Tax free bond issues are simply not the flavour in 2012-13. Reason: lower interest rates compared with those offered in 2011-12. In such a lacklustre market, state-owned Jawaharlal Nehru Port Trust (JNPT) is hitting the market at the fag end of the financial year 2013 with its tax free bonds of Rs 1,000 each to raise Rs 2,000 crore.